Trial Profile
Methotrexate Discontinuation from Combination Therapy with Adalimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting